Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-17

Clinical Trial Update: Evaluation of Neuroprotective Effect of Minocycline [Phase 2]

View source ↗

Summary

Update on a Phase 2 trial evaluating whether minocycline can provide neuroprotection in retinal detachment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Retinal Detachment | Phase 2 | Status: UNKNOWN